OP0220 Randomized, double-blind, global clinical trial to evaluate equivalence of CHS-1420 to adalimumab in patients with psoriasis and psoriatic arthritis

James R. O’Dell, Barbara Finck, Kristian H. R. Jensen et al.|Annals of the Rheumatic Diseases|2017

Cited by 3